Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Effect of Esomeprazole on SYN-004 Degradation of Ceftriaxone
NCT02473640Phase 2Completed
- Sponsor
- Theriva Biologics
- Start
- Jun 2015
- Primary completion
- Apr 2016
- Modality
- Replacement Enzymes
- Countries
- 1
01
Overview
A Phase 2 trial of ribaxamase in Clostridioides difficile infection (CDI), dysbiosis, sponsored by Theriva Biologics. Started Jun 2015; status: completed.
02
Drugs
ribaxamase
03
Conditions
Clostridioides difficile infection (CDI)dysbiosis
Beyond the preview
Go deeper on NCT02473640.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02473640.